| 000 | 01820 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516213246.0 | ||
| 264 | 0 | _c20150114 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1791-2431 | ||
| 024 | 7 |
_a10.3892/or.2014.3182 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Xiaokai | |
| 245 | 0 | 0 |
_aTargeted inhibition of mTORC2 prevents osteosarcoma cell migration and promotes apoptosis. _h[electronic resource] |
| 260 |
_bOncology reports _cJul 2014 |
||
| 300 |
_a382-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 | _aMechanistic Target of Rapamycin Complex 1 |
| 650 | 0 | 4 | _aMechanistic Target of Rapamycin Complex 2 |
| 650 | 0 | 4 |
_aMultiprotein Complexes _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOsteosarcoma _xmetabolism |
| 650 | 0 | 4 |
_aPurines _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
| 650 | 0 | 4 | _aRapamycin-Insensitive Companion of mTOR Protein |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aLai, Pinglin | |
| 700 | 1 | _aZhang, Zhongmin | |
| 700 | 1 | _aHuang, Minjun | |
| 700 | 1 | _aWang, Liang | |
| 700 | 1 | _aYin, Min | |
| 700 | 1 | _aJin, Dadi | |
| 700 | 1 | _aZhou, Rongping | |
| 700 | 1 | _aBai, Xiaochun | |
| 773 | 0 |
_tOncology reports _gvol. 32 _gno. 1 _gp. 382-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/or.2014.3182 _zAvailable from publisher's website |
| 999 |
_c23836857 _d23836857 |
||